Results 241 to 250 of about 2,308,170 (352)
Impact of the COVID-19 pandemic on international business travel and associated health issues: a survey of Japanese public companies. [PDF]
Tsukada YT, Okamura R, Yasutake M.
europepmc +1 more source
Zuranolone: A case study in (regulatory) rush to judgement?
Abstract Sage, in collaboration with Biogen, submitted a new drug approval for zuranolone for postpartum depression (PPD) and major depressive disorder (MDD) in December 2022. In August 2023, the US Food and Drug Administration granted approval for PPD but denied approval for MDD.
Lisa Cosgrove +4 more
wiley +1 more source
The need for clear medical data ownership laws. [PDF]
Klonoff DC +7 more
europepmc +1 more source
Abstract This paper explores the growing influence of young people's activism in UK museums and its educational implications. It draws on a five‐year collaborative programme (2019–2023) with young people of colour (16–28) in a university museum setting, focusing on a Young Collective established to address cultural inequalities.
Sadia Habib
wiley +1 more source
ANALYSIS OF THE RECENT DEVELOPMENTS IN CORPORATE LAW: IMPLICATIONS FOR PRIVATE COMPANIES [PDF]
Ajeet Singh
openalex +1 more source
Abstract As the UK higher education sector becomes increasingly market‐driven and focused on preparing students for the graduate labour market, universities must define and contextualise employability and their role in supporting students beyond academia.
Michael Maher +3 more
wiley +1 more source
The EAES intellectual property protection guide. [PDF]
Nakajima K +4 more
europepmc +1 more source
Abstract Many studies and initiatives are animated by the potential for science education to intervene in the climate crisis and crises of environmental degradation and disinformation. For science teachers to learn to address these issues in their classes, their teaching must expand beyond scientific facts and face controversial social aspects. Dealing
Valeria M. Cabello +2 more
wiley +1 more source

